As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...

Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel ...

Treatment for liver fibrosis may involve managing the underlying cause. There sometimes is a need for a liver transplant.

what it means for the clinical management and treatment of fatty liver, and the need for new MAFLD disease models. The conversation was led by Hirokazu Takahashi, a physician specializing in ...

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led ...

Hepatic steatosis steadily increased in patients with HIV and HCV coinfection despite curative treatment with DAA therapy.

Patients in the treatment arms received 1 mg, 2.5 mg, 5 mg or 10 mg doses. After 52 weeks of treatment, patients taking the ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Carisma Therapeutics Inc. (CARM) presented promising preclinical data on engineered macrophages for treating liver fibrosis at the ...

As liver fibrosis can lead to cirrhosis and increase the risk of liver-related complications, understanding factors that ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three ...